Search: Look for:   Last 1 Month   Last 6 Months   All time

Shingles vaccine cuts risk by 55 pc: Study

Washington , Wed, 12 Jan 2011 ANI

Washington, Jan 12 (ANI): A new study has found that receiving the herpes zoster vaccine is associated with a 55 percent reduced risk of developing shingles, a painful, lingering disease.

 

The Kaiser Permanente researchers observed the outcomes of the effectiveness of the herpes zoster vaccine in a large, diverse population of men and women ages 60 years and older.

 

They found a significant reduced risk of shingles across all sub-groups-those who are healthy as well as those with chronic conditions including diabetes or heart, lung or kidney diseases.

 

Shingles is caused by the dormant chickenpox virus, which stays in the body after a person has recovered from chickenpox. The virus can reactivate and replicate and cause shingles and damage to the nerve system. The elderly are especially vulnerable because as we age, our immunity against the virus that causes shingles declines.

 

The retrospective observational study looked at 75,761 vaccinated and 227,283 unvaccinated male and female members of Kaiser Permanente in Southern California from 2007 to 2009, using electronic health records to compare the incidence of shingles of the vaccinated and unvaccinated populations.

 

The study appeared in the current issue of the Journal of the American Medical Association. (ANI)

 


LATEST IMAGES
Manohar Lal being presented with a memento
Manoj Tiwari BJP Relief meets the family members of late Ankit Sharma
Haryana CM Manohar Lal congratulate former Deputy PM Lal Krishna Advani on his 92nd birthday
King of Bhutan, the Bhutan Queen and Crown Prince meeting the PM Modi
PM Narendra Modi welcomes the King of Bhutan
Post comments:
Your Name (*) :
Your Email :
Your Phone :
Your Comment (*):
  Reload Image
 
 

Comments:


 

OTHER TOP STORIES


Excellent Hair Fall Treatment
Careers | Privacy Policy | Feedback | About Us | Contact Us | | Latest News
Copyright © 2015 NEWS TRACK India All rights reserved.